Expression of the nerve growth factor NGF is increased in pulmonary hypertension (PH). We have here studied whether oxidative stress and inflammation, two pathological conditions associated with transforming growth factor-β1 (TGF-β1) in PH, may trigger NGF secretion by pulmonary arterial (PA) cells. Effects of hydrogen peroxide (H2O2) and interleukin-1β (IL-1β) were investigated ex vivo on rat pulmonary arteries, as well as in vitro on human PA smooth muscle (hPASMC) or endothelial cells (hPAEC). TβRI expression was assessed by Western blotting. NGF PA secretion was assessed by ELISA after TGF-β1 blockade (anti-TGF-β1 siRNA, TGF-β1 blocking antibodies, TβRI kinase, p38 or Smad3 inhibitors). TβRI PA expression was evidenced by Western blotting both ex vivo and in vitro. H2O2 or IL-1β significantly increased NGF secretion by hPASMC and hPAEC, and this effect was significantly reduced when blocking TGF-β1 expression, binding to TβRI, TβRI activity, or signaling pathways. In conclusion, oxidative stress and inflammation may trigger TGF-β1 secretion by hPASMC and hPAEC. TGF-β1 may then act as an autocrine factor on these cells, increasing NGF secretion via TβRI activation. Since NGF and TGF-β1 are relevant growth factors involved in PA remodeling, such mechanisms may therefore be relevant to PH pathophysiology.
We have previously shown a pathophysiological role for NGF in pulmonary hypertension, particularly in pulmonary arterial (PA) hyperreactivity. Our experiments have suggested different mechanisms activated by NGF depending on a short‑ or a long-term PA treatment. The aim of the present study was to determine the mechanisms activated after a NGF short‑term PA treatment (1h). Contractions of rat PA were induced ex vivo by endothelin-1 (ET-1, 10-12-10-6M) in the absence or presence of NGF (100ng/ml, 1h), with or without K252a (TrkA kinase inhibitor, 300nM) or Y‑27632 (ROCK inhibitor, 10µM). NGF‑induced phosphorylation of myosin phosphatase target subunit 1 (MYPT1) was evaluated in vitro by Western blotting in primary human PA smooth muscle cells (hPASMC). Basal and ET-1-induced (10-7M) calcium responses were evaluated in vitro in primary rat PASMC (rPASMC) using calcium imaging (Fura2, Fluo-4), in the absence or presence of NGF (100ng/ml, 1h). Calcium sources involved in NGF-increased calcium concentration were determined using Thapsigargin (1µM), Cyclopiazonic Acid (10µM), or an extracellular medium without Ca²+. Ex vivo, our results show that NGF (1h) induces rat PA hyperreactivity to ET-1 in a TrkA and ROCK dependent-manner. In vitro, NGF (1h) induces MYPT1 phosphorylation in hPASMC and enhances both basal and ET-1-increased intracellular calcium concentrations in rPASMC, with endoplasmic reticulum being the main calcium source contributing to these effects. In conclusion, our results show that NGF induces PA hyperreactivity through activation of its TrkA receptor, leading to both modulation of calcium intracellular concentrations and sensitization mechanisms involving the ROCK pathway.